Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yuen K Y, Chan P K, Peiris M, Tsang D N, Que T L, Shortridge K F, Cheung P T, To W K, Ho E T, Sung R, Cheng A F. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet, 1998, 351(9101): 467–471
Peiris J S, Chu C M, Cheng V C, Chan K S, Hung I F, Poon L L, Law K I, Tang B S, Hon T Y, Chan C S, Chan K H, Ng J S, Zheng B J, Ng W L, Lai R W, Guan Y, Yuen K Y; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet, 2003, 361(9371): 1767–1772
Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet, 2006, 368(9538): 886–889
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood F S, Jain S, Finelli L, Shaw M W, Lindstrom S, Garten R J, Gubareva L V, Xu X, Bridges C B, Uyeki T M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med, 2009, 360(25): 2605–2615
World Health Organization. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec, 2009, 84(46): 481–484
Cao B, Li X W, Mao Y, Wang J, Lu H Z, Chen Y S, Liang Z A, Liang L, Zhang S J, Zhang B, Gu L, Lu L H, Wang D Y, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med, 2009, 361(26): 2507–2517
Domínguez-Cherit G, Lapinsky S E, Macias A E, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres J A, Bautista E, Martinez A, Martinez M A, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart T E, Fowler R A. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA, 2009, 302(17): 1880–1887
Libster R, Bugna J, Coviello S, Hijano D R, Dunaiewsky M, Reynoso N, Cavalieri M L, Guglielmo M C, Areso M S, Gilligan T, Santucho F, Cabral G, Gregorio G L, Moreno R, Lutz M I, Panigasi A L, Saligari L, Caballero M T, Egües Almeida R M, Gutierrez Meyer M E, Neder M D, Davenport M C, Del Valle M P, Santidrian V S, Mosca G, Garcia Domínguez M, Alvarez L, Landa P, Pota A, Boloñati N, Dalamon R, Sanchez Mercol V I, Espinoza M, Peuchot J C, Karolinski A, Bruno M, Borsa A, Ferrero F, Bonina A, Ramonet M, Albano L C, Luedicke N, Alterman E, Savy V, Baumeister E, Chappell J D, Edwards K M, Melendi G A, Polack F P. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med, 2010, 362(1): 45–55
Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep, 2009, 58(27): 749–752
Hewagama S, Walker S P, Stuart R L, Gordon C, Johnson P D, Friedman N D, O’Reilly M, Cheng A C, Giles M L. 2009 H1N1 Influenza A and Pregnancy Outcomes in Victoria, Australia. Clin Infect Dis, 2010, 50(5): 686–690
Jamieson D J, Honein M A, Rasmussen S A, Williams J L, Swerdlow D L, Biggerstaff M S, Lindstrom S, Louie J K, Christ C M, Bohm S R, Fonseca V P, Ritger K A, Kuhles D J, Eggers P, Bruce H, Davidson H A, Lutterloh E, Harris M L, Burke C, Cocoros N, Finelli L, MacFarlane K F, Shu B, Olsen S J; Novel Influenza A (H1N1) Pregnancy Working Group. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet, 2009, 374: 451–458
Louie J K, Acosta M, Jamieson D J, Honein M A; California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med, 2010, 362(1): 27–35
Vaillant L, La Ruche G, Tarantola A, Barboza P; epidemic intelligence team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill, 2009, 14(33), pii: 19309
Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult P A, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature, 2009, 460(7258): 1021–1025
Maines T R, Jayaraman A, Belser J A, Wadford D A, Pappas C, Zeng H, Gustin K M, Pearce M B, Viswanathan K, Shriver Z H, Raman R, Cox N J, Sasisekharan R, Katz J M, Tumpey T M. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science, 2009, 325(5939): 484–487
Munster V J, de Wit E, van den Brand J M, Herfst S, Schrauwen E J, Bestebroer T M, van de Vijver D, Boucher C A, Koopmans M, Rimmelzwaan G F, Kuiken T, Osterhaus A D, Fouchier R A. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science, 2009, 325(5939): 481–483
Yeh E, Luo R F, Dyner L, Hong D K, Banaei N, Baron E J, Pinsky B A. Preferential lower respiratory tract infection in swine-origin 2009 A(H1N1) influenza. Clin Infect Dis, 2010, 50(3): 391–394
Glaser L, Stevens J, Zamarin D, Wilson I A, García-Sastre A, Tumpey T M, Basler C F, Taubenberger J K, Palese P. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol, 2005, 79(17): 11533–11536
Stevens J, Blixt O, Glaser L, Taubenberger J K, Palese P, Paulson J C, Wilson I A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol, 2006, 355(5): 1143–1155
Tumpey T M, Maines T R, Van Hoeven N, Glaser L, Solórzano A, Pappas C, Cox N J, Swayne D E, Palese P, Katz JM, García-Sastre A. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science, 2007, 315(5812): 655–659
Matrosovich M N, Matrosovich T Y, Gray T, Roberts N A, Klenk H D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A, 2004, 101(13): 4620–4624
Soundararajan V, Tharakaraman K, Raman R, Raguram S, Shriver Z, Sasisekharan V, Sasisekharan R. Extrapolating from sequence-the 2009 H1N1 ’swine’ influenza virus. Nat Biotechnol, 2009, 27(6): 510–513
Childs R A, Palma A S, Wharton S, Matrosovich T, Liu Y, Chai W, Campanero-Rhodes M A, Zhang Y, Eickmann M, Kiso M, Hay A, Matrosovich M, Feizi T. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol, 2009, 27(9): 797–799
Yamada S, Suzuki Y, Suzuki T, Le M Q, Nidom C A, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire L F, Stevens D J, Russell R J, Gamblin S J, Skehel J J, Kawaoka Y. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature, 2006, 444(7117): 378–382
Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature, 2006, 440(7083): 435–436
Chan M C, Chan R W, Yu W C, Ho C C, Yuen K M, Fong J H, Tang L L, Lai W W, Lo A C, Chui W H, Sihoe A D, Kwong D L, Wong D S, Tsao G S, Poon L L, Guan Y, Nicholls J M, Peiris J S. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol, 2010, 176(4): 1828–1840
Li IW, Chan K H, To K W, Wong S S, Ho P L, Lau S K, Woo P C, Tsoi H W, Chan J F, Cheng V C, Zheng B J, Chen H, Yuen K Y. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol, 2009, 46(4): 325–330
Ayala E, Kagawa F T, Wehner J H, Tam J, Upadhyay D. Rhabdomyolysis associated with 2009 influenza A(H1N1). JAMA, 2009, 302(17): 1863–1864
D’silva D, Hewagama S, Doherty R, Korman T M, Buttery J. Melting muscles: novel H1N1 influenza A associated rhabdomyolysis. J Pediatr Infect Dis, 2009, 28(12): 1138–1139
Parikh M, Dolson G, Ramanathan V, Sangsiraprapha W. Novel H1N1-associated rhabdomyolysis leading to acute renal failure. Clin Microbiol Infect, 2010, 16(4): 330–332
Riquelme A, Alvarez-Lobos M, Pavez C, Hasbun P, Dabanch J, Cofré C, Jimenez J, Calvo M. Gastrointestinal manifestations among Chilean patients infected with novel influenza A (H1N1) 2009 virus. Gut, 2009, 58(11): 1567–1568
To K K, Chan K H, Li I W, Tsang T Y, Tse H, Chan J F, Hung I F, Lai S T, Leung C W, Kwan Y W, Lau Y L, Ng T K, Cheng V C, Peiris J S, Yuen K Y. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol, 2010, 82(1): 1–7
To K K, Hung I F, Li I W, Lee K L, Koo C K, Yan W W, Liu R, Ho K Y, Chu K H, Watt C L, Luk W K, Lai K Y, Chow F L, Mok T, Buckley T, Chan J F, Wong S S, Zheng B, Chen H, Lau C C, Tse H, Cheng V C, Chan K H, Yuen K Y. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis, 2010, 50(6): 850–859
World Health Organization. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec, 2010, 85(4): 21–22
Veljkovic V, Niman H L, Glisic S, Veljkovic N, Perovic V, Muller C P. Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor. BMC Struct Biol, 2009, 9: 62
Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 2009, 459(7249): 931–939
Garten R J, Davis C T, Russell C A, Shu B, Lindstrom S, Balish A, Sessions W M, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith C B, Emery S L, Hillman M J, Rivailler P, Smagala J, de Graaf M, Burke D F, Fouchier R A, Pappas C, Alpuche-Aranda C M, López-Gatell H, Olivera H, López I, Myers C A, Faix D, Blair P J, Yu C, Keene KM, Dotson P D Jr, Boxrud D, Sambol A R, Abid S H, St George K, Bannerman T, Moore A L, Stringer D J, Blevins P, Demmler-Harrison G J, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara H F, Belongia E A, Clark P A, Beatrice S T, Donis R, Katz J, Finelli L, Bridges C B, Shaw M, Jernigan D B, Uyeki T M, Smith D J, Klimov A I, Cox N J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2009, 325(5937): 197–201
Herfst S, Chutinimitkul S, Ye J, de Wit E, Munster V J, Schrauwen E J, Bestebroer T M, Jonges M, Meijer A, Koopmans M, Rimmelzwaan G F, Osterhaus A D, Perez D R, Fouchier R A. Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol, 2010, 84(8): 3752–3758
Mehle A, Doudna J A. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci U S A, 2009, 106(50): 21312–21316
de Jong M D, Simmons C P, Thanh T T, Hien V M, Smith G J, Chau T N, Hoang DM, Chau N V, Khanh T H, Dong V C, Qui P T, Cam B V, Ha do Q, Guan Y, Peiris J S, Chinh N T, Hien T T, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med, 2006, 12(10): 1203–1207
Martin E T, Kuypers J, Heugel J, Englund J A. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Diagn Microbiol Infect Dis, 2008, 62(4): 382–388
Moltedo B, Lopez C B, Pazos M, Becker M I, Hermesh T, Moran T M. Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol, 2009, 183(6): 3569–3573
Smith G J, Vijaykrishna D, Bahl J, Lycett S J, Worobey M, Pybus O G, Ma S K, Cheung C L, Raghwani J, Bhatt S, Peiris J S, Guan Y, Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature, 2009, 459(7250): 1122–1125
Hancock K, Veguilla V, Lu X, Zhong W, Butler E N, Sun H, Liu F, Dong L, DeVos J R, Gargiullo P M, Brammer T L, Cox N J, Tumpey T M, Katz J M. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med, 2009, 361(20): 1945–1952
Potter C W, Oxford J S. Determinants of immunity to influenza infection in man. Br Med Bull, 1979, 35(1): 69–75
Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet, 2010, 375(9720): 1100–1108
Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, Broman M, Davidkin I, Ziegler T, Julkunen I. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill, 2010, 15(5). pii: 19478
Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, de Jong M D, Farrar J, Riley S, Smith G J, Guan Y. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis, 2009, 15(11): 1849–1850
Zhu F C, Wang H, Fang H H, Yang J G, Lin X J, Liang X F, Zhang X F, Pan H X, Meng F Y, Hu Y M, Liu W D, Li C G, Li W, Zhang X, Hu J M, Peng W B, Yang B P, Xi P, Wang H Q, Zheng J S. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med, 2009, 361(25): 2414–2423
Liang X F, Wang H Q, Wang J Z, Fang H H, Wu J, Zhu F C, Li R C, Xia S L, Zhao Y L, Li F J, Yan S H, Yin W D, An K, Feng D J, Cui X L, Qi F C, Ju C J, Zhang Y H, Guo Z J, Chen P Y, Chen Z, Yan K M, Wang Y. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet, 2010, 375(9708): 56–66
Krause J C, Tumpey T M, Huffman C J, McGraw P A, Pearce M B, Tsibane T, Hai R, Basler C F, Crowe J E Jr. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol, 2010, 84(6): 3127–3130
Manicassamy B, Medina R A, Hai R, Tsibane T, Stertz S, Nistal-Villán E, Palese P, Basler C F, García-Sastre A. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog, 2010, 6(1): e1000745
Bishop J F, Murnane M P, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med, 2009, 361(27): 2591–2594
Chang Y S, van Hal S J, Spencer P M, Gosbell I B, Collett P W. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the “PROTECT” phase of the pandemic response. Med J Aust, 2010, 192(2): 90–93
Rothberg M B, Haessler S D. Complications of seasonal and pandemic influenza. Crit Care Med, 2010, 38(4 suppl): e91–97
Greenbaum J A, Kotturi M F, Kim Y, Oseroff C, Vaughan K, Salimi N, Vita R, Ponomarenko J, Scheuermann R H, Sette A, Peters B. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A, 2009, 106(48): 20365–20370
Xing Z, Cardona C J. Preexisting immunity to pandemic (H1N1) 2009. Emerg Infect Dis, 2009, 15(11): 1847–1849
Ge X, Tan V, Bollyky P L, Standifer N E, James E A, KwokW W. Assessment of seasonal influenza A specific CD4 T cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol, 2010, 84(7): 3312–3319
McMichael A J, Gotch F M, Noble G R, Beare P A. Cytotoxic T-cell immunity to influenza. N Engl J Med, 1983, 309(1): 13–17
Doherty P C, Turner S J, Webby R G, Thomas P G. Influenza and the challenge for immunology. Nat Immunol, 2006, 7(5): 449–455
Achdout H, Meningher T, Hirsh S, Glasner A, Bar-On Y, Gur C, Porgador A, Mendelson M, Mandelboim M, Mandelboim O. Killing of avian and swine influenza by natural killer cells. J Virol, 2010, 84(8): 3993–4001
Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, Luo W, Chen T, Qin Q, Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med, 2005, 171(8): 850–857
Woo P C, Tung E T, Chan K H, Lau C C, Lau S K, Yuen K Y. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis, 2010, 201(3): 346–353
Osterlund P, Pirhonen J, Ikonen N, Rönkkö E, Strengell M, Mäkelä S M, Broman M, Hamming O J, Hartmann R, Ziegler T, Julkunen I. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol, 2010, 84(3): 1414–1422
Lee M H, Arrecubieta C, Martin F J, Prince A, Borczuk A C, Lowy F D. A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis, 2010, 201(4): 508–515
Mauad T, Hajjar L A, Callegari G D, da Silva L F, Schout D, Galas F R, Alves V A, Malheiros DM, Auler J O Jr, Ferreira A F, Borsato M R, Bezerra S M, Gutierrez P S, Caldini E T, Pasqualucci C A, Dolhnikoff M, Saldiva P H. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med, 2010, 181(4): 72–79
Bermejo-Martin J F, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, Martin-Loeches I, Varillas D, Gallegos M C, Seron C, Micheloud D, Gomez J M, Tenorio-Abreu A, Ramos M J, Molina M L, Huidobro S, Sanchez E, Gordon M, Fernandez V, Del Castillo A, Marcos M A, Villanueva B, Lopez C J, Rodriguez-Dominguez M, Galan J C, Canton R, Lietor A, Rojo S, Eiros J M, Hinojosa C, Gonzalez I, Torner N, Banner D, Leon A, Cuesta P, Rowe T, Kelvin D J. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care, 2009, 13(6): R201
Srivastava B, Błazejewska P, Hessmann M, Bruder D, Geffers R, Mauel S, Gruber A D, Schughart K. Host genetic background strongly influences the response to influenza a virus infections. PLoS One, 2009, 4(3): e4857
Shapira S D, Gat-Viks I, Shum B O, Dricot A, de Grace M M, Wu L, Gupta P B, Hao T, Silver S J, Root D E, Hill D E, Regev A, Hacohen N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell, 2009, 139(7): 1255–1267
Brass A L, Huang I C, Benita Y, John S P, Krishnan M N, Feeley E M, Ryan B J, Weyer J L, van der Weyden L, Fikrig E, Adams D J, Xavier R J, Farzan M, Elledge S J. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell, 2009, 139(7): 1243–1254
Karlas A, Machuy N, Shin Y, Pleissner K P, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie L A, Hess S, Mäurer A P, Müller E, Wolff T, Rudel T, Meyer T F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature, 2010, 463(7282): 818–822
König R, Stertz S, Zhou Y, Inoue A, Heinrich Hoffmann H, Bhattacharyya S, Alamares J G, Tscherne D M, Ortigoza M B, Liang Y, Gao Q, Andrews S E, Bandyopadhyay S, De Jesus P, Tu B P, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, Garcia-Sastre A, Young J A, Palese P, Shaw M L, Chanda S K. Human host factors required for influenza virus replication. Nature, 2010, 463(7282): 813–817
Gordon C L, Johnson P D, Permezel M, Holmes N E, Gutteridge G, McDonald C F, Eisen D P, Stewardson A J, Edington J, Charles P G, Crinis N, Black M J, Torresi J, Grayson M L. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis, 2010, 50(5): 672–678
Watkins J, Tee D E. Catabolism of gamma G-globulin and myeloma proteins of the subclasses gamma G1 and gamma G2 in a healthy volunteer. Immunology, 1970, 18(4): 537–543
ANZIC Influenza Investigators, Webb S A, Pettila V, Seppelt I, Bellomo R, Bailey M, Cooper D J, Cretikos M, Davies A R, Finfer S, Harrigan P W, Hart G K, Howe B, Iredell J R, McArthur C, Mitchell I, Morrison S, Nichol A D, Paterson D L, Peake S, Richards B, Stephens D, Turner A, Yung M. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med, 2009, 361(20): 1925–1934
Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby C E, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos J A; INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med, 2009, 361(7): 680–689
Taubenberger J K, Morens D M. The pathology of influenza virus infections. Annu Rev Pathol, 2008, 3: 499–522
Ulvestad E, Kanestrom A, Tengner P, Gjerde S, Sundal J, Haga H J. Anti-cardiolipin autoantibodies and pulmonary embolism. A case for a common cause. Scand J Rheumatol, 2000, 29(5): 330–333
Gill J R, Sheng Z M, Ely S F, Guinee D G, Beasley M B, Suh J, Deshpande C, Mollura D J, Morens D M, Bray M, Travis W D, Taubenberger J K. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med, 2010, 134(2): 235–243
Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep, 2009, 58(38): 1071–1074
Cheng V C, Lau Y K, Lee K L, Yiu K H, Chan K H, Ho P L, Yuen K Y. Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus. J Infect, 2009, 59(5): 366–370
Brundage J F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis, 2006, 6(5): 303–312
Tashiro M, Ciborowski P, Reinacher M, Pulverer G, Klenk H D, Rott R. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology, 1987, 157(2): 421–430
Martin S S, Hollingsworth C L, Norfolk S G, Wolfe C R, Hollingsworth JW. Reversible cardiac dysfunction associated with pandemic-2009-H1N1 influenza A. Chest, 2010 Feb 5. [Epub ahead of print]
Silva-Herzog E, Detweiler C S. Intracellular microbes and haemophagocytosis. Cell Microbiol, 2008, 10(11): 2151–2158
World Health Organization. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. http://www.who.int/csr/resources/publications/swineflu/clinical_management_h1n1.pdf . Accessed 10 February 2010
Centers for Disease Control and Prevention (CDC). Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep, 2009, 58(16): 433–435
Jain S, Kamimoto L, Bramley A M, Schmitz A M, Benoit S R, Louie J, Sugerman D E, Druckenmiller J K, Ritger K A, Chugh R, Jasuja S, Deutscher M, Chen S, Walker J D, Duchin J S, Lett S, Soliva S, Wells E V, Swerdlow D, Uyeki T M, Fiore A E, Olsen S J, Fry A M, Bridges C B, Finelli L; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med, 2009, 361(20): 1935–1944
Li I W, Hung I F, To K K, Chan K H, Wong S S, Chan J F, Cheng V C, Tsang O T, Lai S T, Lau Y L, Yuen K Y. The natural viral load profile of patients with pandemic swine-origin influenza A H1N1 2009 (pH1N1) and the effect of oseltamivir treatment. Chest, 2010, 137(4): 759–768
Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients- Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep, 2009, 58(32): 893–896
Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morb Mortal Wkly Rep, 2009, 58(35): 969–972
Chen H, Cheung C L, Tai H, Zhao P, Chan J F, Cheng V C, Chan K H, Yuen K Y. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis, 2009, 15(12): 1970–1972
Gulland A. First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales. BMJ, 2009, 339: b4975
Leung T W, Tai A L, Cheng P K, Kong M S, Lim W. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. J Clin Virol, 2009, 46(3): 298–299
Speers D J, Williams S H, Pinder M, Moody H R, Hurt A C, Smith D W. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case. Med J Aust, 2010, 192(3): 166–168
World Health Organization. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly Epidemiol Rec, 2010, 85(6): 37–40
Le Q M, Wertheim H F, Tran N D, van Doorn H R, Nguyen T H, Horby P; Vietnam H1N1 Investigation Team. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med, 2010, 362(1): 86–87
Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin M E, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med, 2009, 361(23): 2296–2297
Gaur A H, Bagga B, Barman S, Hayden R, Lamptey A, Hoffman J M, Bhojwani D, Flynn P M, Tuomanen E, Webby R. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med, 2010, 362(1): 88–89
Kidd IM, Down J, Nastouli E, Shulman R, Grant P R, Howell D C, Singer M. H1N1 pneumonitis treated with intravenous zanamivir. Lancet, 2009, 374(9694): 1036
Hurt A C, Holien J K, Parker M, Kelso A, Barr I G. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol, 2009, 83(20): 10366–10373
Hurt A C, Ernest J, Deng Y M, Iannello P, Besselaar T G, Birch C, Buchy P, Chittaganpitch M, Chiu S C, Dwyer D, Guigon A, Harrower B, Kei I P, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D’souza H, Komadina N, Shaw R, Kelso A, Barr I G. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res, 2009, 83(1): 90–93
Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis, 2009, 48 Suppl 1: S3–13
Triana-Baltzer G B, Gubareva L V, Nicholls J M, Pearce M B, Mishin V P, Belser J A, Chen LM, Chan RW, ChanMC, Hedlund M, Larson J L, Moss R B, Katz J M, Tumpey T M, Fang F. Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One, 2009, 4(11): e7788
Pleschka S, Stein M, Schoop R, Hudson J B. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J, 2009, 6: 197
Luke T C, Kilbane E M, Jackson J L, Hoffman S L. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med, 2006, 145(8): 599–609
Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med, 2007, 357: 1450–1451
Koudstaal W, Koldijk M H, Brakenhoff J P, Cornelissen L A, Weverling G J, Friesen R H, Goudsmit J. Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir. J Infect Dis, 2009, 200(12): 1870–1873
Wu J T, Lee C K, Cowling B J, Yuen K Y. Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Natl Acad Sci U S A, 2010, 107(7): 3269–3274
Quispe-Laime A M, Bracco J D, Barberio P A, Campagne C G, Rolfo V E, Umberger R, Meduri G U. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med, 2010, 36(1): 33–41
Carter M J. A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J Med Microbiol, 2007, 56(Pt 7): 875–883
Zheng B J, Chan K W, Lin Y P, Zhao G Y, Chan C, Zhang H J, Chen H L,Wong S S, Lau S K,Woo P C, Chan K H, Jin D Y, Yuen K Y. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A, 2008, 105(23): 8091–8096